Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 4.1 EX-4.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 16.1 EX-16.1
- 23.1 EX-23.1
VKTX similar filings
Filing view
External links
Exhibit 16.1
July 1, 2014
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
RE: Viking Therapeutics, Inc.
We have read the statements under the section “Changes in and Disagreements with Independent Registered Public Accounting Firm
on Accounting and Financial Disclosure” in the Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on July 1, 2014 regarding the change of auditors. We agree with all statements pertaining to us.
We have no basis to agree or disagree with statements pertaining to the successor accountants.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, TX